Literature DB >> 20584357

Extending influenza vaccination to individuals aged 50-64: a budget impact analysis.

Americo Cicchetti1, Matteo Ruggeri, Lara Gitto, Francesco Saverio Mennini.   

Abstract

OBJECTIVES: Influenza (vernacular name, flu) is a viral infection that causes a high consumption of resources. Several studies have been carried out to provide an economic evaluation of the vaccination programs against influenza. Nevertheless, there is still a lack of evidence about the dynamic effects resulting from the reduction of the transmission power. This study considers the impact on contagiousness of alternative strategies against influenza in people aged 50-64 in Italy, France, Germany, and Spain.
METHODS: By using the Influsim 2.0 dynamic model, we have determined the social benefits of different coverage levels in every country compared with the ones currently recommended. We have subsequently performed a Budget Impact Analysis to determine whether the currently recommended coverage results from an optimal budget allocation. A probabilistic sensitivity analysis was also conducted.
RESULTS: We found that in Germany, the optimal coverage level is 38.5 percent, in France 32.4 percent, in Italy 32.75 percent, and 28.3 percent in Spain. By extending the coverage level, social saving tends to increase up to 100 percent for France and Italy and up to 80 percent for Germany and Spain.
CONCLUSIONS: Decision makers should allocate the budget for vaccination against influenza consistently with the estimation of the optimal coverage level and with the dynamic effects resulting from the reduction of the transmission power.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584357     DOI: 10.1017/S0266462310000280

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

1.  Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study.

Authors:  Francesco Saverio Mennini; Gianluca Baio; Giuseppe Montagano; Gabriella Cauzillo; Francesco Locuratolo; Gerardo Becce; Lara Gitto; Andrea Marcellusi; Peter Zweifel; Alessandro Capone; Giampiero Favato
Journal:  BMJ Open       Date:  2012-03-15       Impact factor: 2.692

2.  Estimating the burden of influenza-associated hospitalization and deaths in Oman (2012-2015).

Authors:  Doaa M Abdel-Hady; Rima M Al Balushi; Badr A Al Abri; Seif S Al Abri; Hanan S Al Kindi; Amina K Al-Jardani; Fatma M Al Yaqubi; Idris S Al Abaidani
Journal:  Influenza Other Respir Viruses       Date:  2017-12-05       Impact factor: 4.380

3.  Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.

Authors:  Francesco Saverio Mennini; Chiara Bini; Andrea Marcellusi; Alessandro Rinaldi; Elisabetta Franco
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

4.  Clinical spectrum, risk factors, and outcomes of children with laboratory-confirmed influenza infection managed in a single tertiary hospital: A 6-year retrospective cohort study.

Authors:  Alya Al Ali; Najla Al Kuwaiti; Eiman Al Kaabi; Salwa Al Kaabi; Aysha Al Kaabi; Hassib Narchi
Journal:  Health Sci Rep       Date:  2021-11-17

5.  Estimating the burden of influenza-associated hospitalizations and deaths in Central America.

Authors:  Miguel A Descalzo; Wilfrido Clara; Guiselle Guzmán; Ricardo Mena; Julio Armero; Bredy Lara; Carlos Saenz; Anabela Aragón; Rafael Chacón; Nathalie El-Omeiri; Jairo Méndez-Rico; Mauricio Cerpa; Rakhee Palekar; Jorge Jara; Eduardo Azziz-Baumgartner
Journal:  Influenza Other Respir Viruses       Date:  2016-03-29       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.